These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32167686)

  • 1. [The role of Epstein-Barr viral infection and hepatitis B and C in liver pathology.].
    Solomay TV; Semenenko TA; Ivanova MY
    Vopr Virusol; 2019; 64(5):215-220. PubMed ID: 32167686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Viral hepatitis B, C and infectious mononucleosis: epidemiological similarities and differences.].
    Solomay TV; Semenenko TA
    Vopr Virusol; 2020; 65(1):27-34. PubMed ID: 32496718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
    Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
    J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?
    Bertoletti A; Maini MK
    Curr Opin Microbiol; 2000 Aug; 3(4):387-92. PubMed ID: 10972499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Hepatitis E Virus infection with coincident reactivation of Epstein-Barr virus infection in an immunosuppressed patient with rheumatoid arthritis: a case report.
    Schultze D; Mani B; Dollenmaier G; Sahli R; Zbinden A; Krayenbühl PA
    BMC Infect Dis; 2015 Oct; 15():474. PubMed ID: 26511098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploitation of host clock gene machinery by hepatitis viruses B and C.
    Vinciguerra M; Mazzoccoli G; Piccoli C; Tataranni T; Andriulli A; Pazienza V
    World J Gastroenterol; 2013 Dec; 19(47):8902-9. PubMed ID: 24379614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes.
    Kimura H; Nagasaka T; Hoshino Y; Hayashi N; Tanaka N; Xu JL; Kuzushima K; Morishima T
    Hum Pathol; 2001 Jul; 32(7):757-62. PubMed ID: 11486177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection.
    Cheng X; Uchida T; Xia Y; Umarova R; Liu CJ; Chen PJ; Gaggar A; Suri V; Mücke MM; Vermehren J; Zeuzem S; Teraoka Y; Osawa M; Aikata H; Tsuji K; Mori N; Hige S; Karino Y; Imamura M; Chayama K; Liang TJ
    J Clin Invest; 2020 Jun; 130(6):3205-3220. PubMed ID: 32163375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A look behind closed doors: interaction of persistent viruses with dendritic cells.
    Lambotin M; Raghuraman S; Stoll-Keller F; Baumert TF; Barth H
    Nat Rev Microbiol; 2010 May; 8(5):350-60. PubMed ID: 20372157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral-Associated GN: Hepatitis B and Other Viral Infections.
    Kupin WL
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1529-1533. PubMed ID: 27797900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.
    Piriou E; van Dort K; Otto S; van Oers MH; van Baarle D
    Clin Infect Dis; 2008 Jan; 46(2):313-6. PubMed ID: 18171268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells.
    Zaghloul H; El-Sherbiny W
    Immunol Invest; 2010 Jan; 39(3):284-91. PubMed ID: 20380524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
    Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study.
    Chiu HY; Hui RC; Huang YH; Huang RY; Chen KL; Tsai YC; Lai PJ; Wang TS; Tsai TF
    Acta Derm Venereol; 2018 Oct; 98(9):829-834. PubMed ID: 29972221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-induced immune dysregulation as a triggering factor for the development of drug rashes and autoimmune diseases: with emphasis on EB virus, human herpesvirus 6 and hepatitis C virus.
    Mizukawa Y; Shiohara T
    J Dermatol Sci; 2000 Apr; 22(3):169-80. PubMed ID: 10698154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis.
    Selmi C; Ceribelli A; Vierling JM
    Semin Immunopathol; 2013 Jan; 35(1):1-5. PubMed ID: 23250654
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr virus associated acute hepatitis with cross-reacting antibodies to other herpes viruses in immunocompetent patients: report of two cases.
    Gupta E; Bhatia V; Choudhary A; Rastogi A; Gupta NL
    J Med Virol; 2013 Mar; 85(3):519-23. PubMed ID: 23297155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal model for study of human hepatitis viruses.
    Chayama K; Hayes CN; Hiraga N; Abe H; Tsuge M; Imamura M
    J Gastroenterol Hepatol; 2011 Jan; 26(1):13-8. PubMed ID: 21175788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of hepatitis B and hepatitis C virus infections.
    Boonstra A; Woltman AM; Janssen HL
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1049-61. PubMed ID: 19187866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.